1 June 2016 in Nature Communications
Focal cortical dysplasia (FCD), a local malformation of cortical development, is the most common cause of pharmacoresistant epilepsy associated with life-long neurocognitive impairments. It remains unclear whether neuronal misplacement is required for seizure activity. Here we show that dyslamination and white matter heterotopia are not necessary for seizure generation in a murine model of type II FCDs. These experimental FCDs generated by increasing mTOR activity in layer 2/3 neurons of the medial prefrontal cortex are associated with tonic-clonic seizures and a normal survival rate. Preventing all FCD-related defects, including neuronal misplacement and dysmorphogenesis, with rapamycin treatments from birth eliminates seizures, but seizures recur after rapamycin withdrawal. In addition, bypassing neuronal misplacement and heterotopia using inducible vectors do not prevent seizure occurrence. Collectively, data obtained using our new experimental FCD-associated epilepsy suggest that life-long treatment to reduce neuronal dysmorphogenesis is required to suppress seizures in individuals with FCD.
26 February 2013 in International Journal of Developmental Neuroscience
30 May 2016 in Nature Neuroscience
1 January 2017 in Neuroscience Letters
19 September 2016 in Proceedings of the National Academy of Sciences
Significance: Increased mammalian target of rapamycin complex 1 (mTORC1) signaling is associated with many neurological and neurodevelopmental disorders, ranging from epilepsy to autism, that feature developmental defects in the organization of the cortex. Despite the fact that much research has focused on mTORC1-related disorders, the downstream effectors that produce these developmental defects are not well understood. To begin filling that void, this study looked at the role of one of the many cellular processes regulated by mTORC1, cap-dependent translation. Surprisingly, normalizing signaling through only one of mTORC1’s targets [eukaryotic initiation factor 4E-binding proteins (4E-BPs)] was able to block ectopic placement of cortical neurons, and mimicking mTORC1 signaling through 4E-BP alone was sufficient to induce neuron misplacement.